Skip to main content

Peer Review reports

From: Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis

Original Submission
9 Jul 2010 Submitted Original manuscript
1 Oct 2010 Author responded Author comments - Ren Liu
22 Aug 2010 Reviewed Reviewer Report - Richard Sainson
7 Sep 2010 Reviewed Reviewer Report - Andreas Fischer
Resubmission - Version 2
1 Oct 2010 Submitted Manuscript version 2
28 Oct 2010 Author responded Author comments - Ren Liu
Resubmission - Version 3
28 Oct 2010 Submitted Manuscript version 3
Publishing
23 Nov 2010 Editorially accepted
23 Nov 2010 Article published 10.1186/1471-2407-10-641

You can find further information about peer review here.

Back to article page